Nicotinic acetylcholine receptor immunohistochemistry in Alzheimer's disease and dementia with Lewy bodies: differential neuronal and astroglial pathology

被引:51
作者
Teaktong, T
Graham, AJ
Court, JA
Perry, RH
Jaros, E
Johnson, M
Hall, R
Perry, EK
机构
[1] Newcastle Gen Hosp, Ctr Dev Clin Brain Aging, Newcastle Upon Tyne NE4 6BE, Tyne & Wear, England
[2] Newcastle Gen Hosp, Dept Neuropathol, Newcastle Upon Tyne NE4 6BE, Tyne & Wear, England
关键词
cholinergic receptors; dementia; neuroglia; limbic system; parahippocampal gyrus;
D O I
10.1016/j.jns.2004.06.015
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Alzheimer's disease (AD) and dementia with Lewy bodies (DLB) are common forms of dementia in the elderly. The neuropathology of AD and DLB is related to cholinergic dysfunctions, and both alpha4 and alpha7 nicotinic acetylcholine receptor (nAChR) subunits are decreased in several brain areas in both diseases. In this immunohistochemical study, we compared neuronal and astroglial alpha4 and alpha7 subunits in AD, DLB and age-matched controls in the hippocampal formation. The numbers of alpha4 reactive neurons were decreased in layer 3 of the entorhinal cortex of AD and DLB, whereas those of alpha7 reactive neurons were decreased in layer 2 of the subiculum of AD and DLB and in layer 3 of the entorhinal cortex of DLB. In contrast, the intensity of alpha7 reactive neuropil was significantly higher in AD than in controls or DLB in a number of areas of the hippocampus (CA3/4 and stratum granulosum), subiculum and entorhinal cortex. An increase in alpha7 immunoreactivity in AD was also associated with astrocytes. The number of astrocytes double-labelled with alpha7 and glial fibrillary acidic protein (GFAP) antibodies was increased in most areas of the hippocampus and entorhinal cortex in AD compared with controls and DLB. Increased astrocyte alpha7 nAChRs in AD may be associated with inflammatory mechanisms related to degenerative processes specific to this disease. (C) 2004 Elsevier B.V. All rights reserved.
引用
收藏
页码:39 / 49
页数:11
相关论文
共 54 条
[1]  
Amaral D.G., 1990, HUMAN NERVOUS SYSTEM, P711, DOI 10.1016/C2009-0-02721-4
[2]   Consensus recommendations for the postmortem diagnosis of Alzheimer's disease [J].
Ball, M ;
Braak, H ;
Coleman, P ;
Dickson, D ;
Duyckaerts, C ;
Gambetti, P ;
Hansen, L ;
Hyman, B ;
Jellinger, K ;
Markesbery, W ;
Perl, D ;
Powers, J ;
Price, J ;
Trojanowski, JQ ;
Wisniewski, H ;
Phelps, C ;
Khachaturian, Z .
NEUROBIOLOGY OF AGING, 1997, 18 (04) :S1-S2
[3]  
Bontempi B, 2001, J PHARMACOL EXP THER, V299, P297
[4]   NEUROPATHOLOGICAL STAGING OF ALZHEIMER-RELATED CHANGES [J].
BRAAK, H ;
BRAAK, E .
ACTA NEUROPATHOLOGICA, 1991, 82 (04) :239-259
[5]  
Burghaus L, 2000, MOL BRAIN RES, V76, P385
[6]   Interleukin-1β activates forebrain glial cells and increases nitric oxide production and cortical glutamate and GABA release in vivo:: Implications for Alzheimer's disease [J].
Casamenti, F ;
Prosperi, C ;
Scali, C ;
Giovannelli, L ;
Colivicchi, MA ;
Faussone-Pellegrini, MS ;
Pepeu, G .
NEUROSCIENCE, 1999, 91 (03) :831-842
[7]   ALPHA-BUNGAROTOXIN-SENSITIVE HIPPOCAMPAL NICOTINIC RECEPTOR-CHANNEL HAS A HIGH-CALCIUM PERMEABILITY [J].
CASTRO, NG ;
ALBUQUERQUE, EX .
BIOPHYSICAL JOURNAL, 1995, 68 (02) :516-524
[8]   Nitric oxide synthases:: targets for therapeutic strategies in neurological diseases [J].
Chabrier, PE ;
Demerlé-Pallardy, C ;
Auguet, M .
CELLULAR AND MOLECULAR LIFE SCIENCES, 1999, 55 (8-9) :1029-1035
[9]   Neuronal nicotinic receptors, important new players in brain function [J].
Clementi, F ;
Fornasari, D ;
Gotti, C .
EUROPEAN JOURNAL OF PHARMACOLOGY, 2000, 393 (1-3) :3-10
[10]  
Combs CK, 2001, J NEUROSCI, V21, P1179